News

Automotive Axles Q1 Results

CONCOR Q1 Results

CCL Products Q1 Results

Gujarat Gas Q1 Results

Britannia Q1 Results

Godawari Power Q1 Results

Torrent Power Q1 Results

Bharti Hexacom Q1 Results

Bharti Airtel Q1 Results

NCC Q1  Results  

Raymond Realty Q1 Results

Gland Pharma Q1 Results

Gokaldas Exports Q1 Results

Jindal Saw Q1 Results

Net Profit down 44% At Rs 14.5 Cr Vs Rs 26 Cr (YoY)

Revenue down 35% At Rs 273 Cr Vs Rs 422 Cr (YoY)

EBITDA down 69% At Rs 13.4 Cr Vs Rs 43.4 Cr (YoY)

Margin At 5% Vs 10% (YoY)

In a press release post results, Exide said that the prices of input materials continue to remain on an increasing trend and hence there remains a continuous pressure on material costs, which is getting offset from the benefits accruing from various cost excellence projects.

here

Net Profit up 5.2% At Rs 244 Cr Vs Rs 232 Cr (YoY)

Revenue up 7.2% At Rs 1,497 Cr Vs Rs 1,397.5 Cr (YoY)

EBITDA up 8.8% At Rs 350 Cr Vs Rs 321.5 Cr (YoY)

Margin At 23.4% Vs 23% (YoY)

Net Profit down 11% At Rs 315 Cr Vs Rs 353.6 Cr (YoY)

Revenue up 3.6% At Rs 3,201 Cr Vs Rs 3,091 Cr (YoY)

EBITDA up 1.2% At Rs 528.5 Cr Vs Rs 522 Cr (YoY)

Margin At 16.5% Vs 17% (YoY)

Net Profit At Rs 14.8 Cr Vs Rs 6.2 Cr (YoY)

EBITDA up 72% At Rs 28.4 Cr Vs Rs 16.5 Cr (YoY)

Margin At 18% Vs 13% (YoY)

Revenue up 22.3% At Rs 156.5 Cr  Vs Rs 128 Cr (YoY)

Net Profit up 40% At Rs 42 Cr Vs Rs 30 Cr (YoY)

Revenue up 22% At Rs 258 Cr Vs Rs 212 Cr (YoY)

EBITDA up 20% At Rs 65 Cr Vs Rs 54 Cr (YoY)

Margin At 25% Vs 25.4% (YoY)

Net Profit up 2.4% At Rs 30 Cr Vs Rs 29.3 Cr (YoY)

Revenue up 7% At Rs 374 Cr Vs Rs 349 Cr (YoY)

EBITDA up 9% At Rs 54 Cr Vs Rs 49.3 Cr (YoY)

Margin Flat At 14% (YoY)

BLS International Net Profit up 50% At Rs 171 Cr Vs Rs 114 Cr (YoY)

Revenue up 44.3% At Rs 710.6 Cr Vs Rs 492.6 Cr (YoY)

EBITDA up 54% At Rs 204.5Cr Vs Rs 133 Cr (YoY)

Margin At 29% Vs 27% (YoY)

Net Profit up 71% At Rs 184 Cr Vs Rs 108 Cr (YoY)

Revenue up 9%  At Rs 1,281 Cr Vs Rs 1,176 Cr (YoY)

EBITDA up 31% At Rs 344 Cr Vs Rs 262 Cr (YoY)

Margin At 27% Vs 22.3% (YoY)

Net Loss At Rs 13.3 Cr Vs Loss Of Rs 25.50 Cr (YoY)

Revenue up 9% At Rs 412 Cr Vs Rs 378.5 Cr (YoY)

EBITDA Loss At Rs 29.40 Cr Vs EBITDA Loss Of Rs 41 Cr (YoY)

Net Profit up 6.5% At Rs 3,314.6 Cr  Vs Rs 3,113 Cr (YoY)

Revenue up 21% At Rs 9,126 Cr Vs Rs 7,559 Cr (YoY)

EBITDA up 13% At Rs 5,495 Cr Vs Rs 4,847 Cr (YoY)

Margin At 60.2% Vs 64.1% (YoY)

Alembic Pharmaceuticals on Tuesday, August 5, announced its June quarter results, in which its net profit increased by 15% to ₹154 crore. This when compared to ₹135 crore in the same quarter last year (year-on-year).

Revenue rose by 10% to ₹1,711 crore, as against ₹1,562 crore in the year-ago period.

here

Net Profit up 14.6% At Rs 320.5 Cr Vs Rs 279.6 Cr (YoY)

Revenue up 4.6% At Rs 4,509.8 Cr Vs Rs 4,312.8 Cr (YoY)

EBITDA up 10.8% At Rs 548 Cr Vs Rs 494.6 Cr (YoY)

Margin At 12.2% Vs 11.5% (YoY)

Net profit (GU)41.7% at ₹118 crore vs ₹83.3 crore (YoY)

Revenue (GU)7.4% at ₹773 crore vs ₹720 crore (YoY)

EBITDA (GU)10.8% at ₹277 crore vs ₹250 crore (YoY)

Margin at 35.8% vs 34.71% (YoY)NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.